Screening for critical heart defects with extra blood flow checks
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial tests if adding blood flow measurements to standard pulse oximeter screening better detects critical congenital heart disease in fetuses and newborns. It may help identify babies who need early heart care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are either a fetus thought to have a heart problem or a newborn (less than 22 days old).
- Newborns may have a confirmed or suspected serious heart condition, or be symptom-free and getting routine oxygen screening.
- Your baby must not have had an echocardiogram (heart ultrasound) already if they are symptom-free and getting oxygen screening.
- If your baby has a confirmed or suspected heart condition, they cannot have only a duct or small hole without other defects.
- Your baby must not have had heart surgery or a catheter procedure already.
- Your baby cannot be on heart medications except for prostaglandin therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how well blood flows to the brain in infants with serious heart defects. The results may help doctors understand and protect brain development before and after heart surgery.
This study looks at how to improve care for babies with serious heart defects, both before and after birth. It brings together pregnancy and newborn care to help identify and treat these heart problems as early as possible.
This trial tests a coordinated treatment plan for newborns with critical congenital heart disease, starting before birth and continuing after delivery. It aims to improve outcomes for babies who need two-ventricle repair surgery.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
This study tests a special sensor (near-infrared spectroscopy) that checks blood flow to the heart and other organs during heart surgery. It may help doctors monitor and improve care for children having complex heart procedures.
This study is testing a new, non-invasive way to measure hemoglobin (the part of blood that carries oxygen) using a light sensor on the skin, without needing extra blood draws. The goal is to see if this sensor is accurate for children having heart procedures, which could reduce the number of needle sticks they need.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.